We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,848 hedge funds and large institutions have $156B invested in Thermo Fisher Scientific in 2020 Q3 according to their latest regulatory filings, with 171 funds opening new positions, 628 increasing their positions, 775 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more first-time investments, than exits

New positions opened: 171 | Existing positions closed: 56

22% more capital invested

Capital invested by funds: $128B → $156B (+$27.5B)

21% more funds holding in top 10

Funds holding in top 10: 163198 (+35)

6% more funds holding

Funds holding: 1,7491,848 (+99)

0.32% less ownership

Funds ownership: 89.48%89.16% (-0.32%)

18% less call options, than puts

Call options by funds: $613M | Put options by funds: $747M

19% less repeat investments, than reductions

Existing positions increased: 628 | Existing positions reduced: 775

Holders
1,848
Holders Change
+99
Holders Change %
+5.66%
% of All Funds
37.28%
Holding in Top 10
198
Holding in Top 10 Change
+35
Holding in Top 10 Change %
+21.47%
% of All Funds
3.99%
New
171
Increased
628
Reduced
775
Closed
56
Calls
$613M
Puts
$747M
Net Calls
-$134M
Net Calls Change
-$153M
Name Holding Trade Value Shares
Change
Change in
Stake
BCAM
851
Boston Common Asset Management
Massachusetts
$3.16M -$1.07M -2,590 -27%
COF
852
Capital One Financial
Virginia
$3.15M -$6.2K -15 -0.2%
NIA
853
Northstar Investment Advisors
Colorado
$3.15M +$1.85M +4,477 +169%
PAI
854
Pittenger & Anderson Inc
Nebraska
$3.13M +$131K +316 +5%
AA
855
AlphaMark Advisors
Kentucky
$3.12M -$750K -1,816 -20%
EHWM
856
Eads & Heald Wealth Management
Georgia
$3.11M -$472K -1,143 -14%
IMRF
857
Illinois Municipal Retirement Fund
Illinois
$3.09M +$2.01M +4,856 +227%
SA
858
Strategic Advisors
New York
$3.08M -$134K -324 -5%
SC
859
Slow Capital
California
$3.08M +$49.6K +120 +2%
CIC
860
Crawford Investment Counsel
Georgia
$3.07M +$17.8K +43 +0.6%
FRA
861
Front Row Advisors
California
$3.06M +$15.3K +37 +0.6%
FC
862
Ferris Capital
Massachusetts
$3.05M +$10.3K +25 +0.4%
KCM
863
Kornitzer Capital Management
Kansas
$3.05M -$69.8K -169 -2%
OGC
864
Oak Grove Capital
New Hampshire
$3.04M -$37.2K -90 -1%
BO
865
Bank OZK
Arkansas
$3.03M -$88.8K -215 -3%
EBT
866
Enterprise Bank & Trust
Massachusetts
$3.02M -$158K -383 -5%
APWM
867
Atlas Private Wealth Management
New York
$3M -$124K -301 -4%
NFC
868
Northeast Financial Consultants
Connecticut
$3M -$2.89K -7 -0.1%
UR
869
USCA RIA
Texas
$3M -$5.37K -13 -0.2%
CPIA
870
Cornell Pochily Investment Advisors
New York
$2.99M -$30.2K -73 -1%
CCI
871
Columbus Circle Investors
$2.96M -$12.3M -29,669 -82%
DR
872
Davis Rea
Ontario, Canada
$2.92M +$35.9K +87 +1%
ST
873
Smithfield Trust
Pennsylvania
$2.92M +$16.1K +39 +0.6%
SW
874
SVB Wealth
Massachusetts
$2.92M +$760K +1,840 +39%
BMC
875
Beaton Management Company
Massachusetts
$2.91M

TMO Hedge Fund Activity: Q3 2020 in Review

1,848 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2020, worth a combined $156B — up 22% from $128B a quarter earlier.

Buyers outnumbered sellers: 171 funds opened new TMO positions and 56 closed out — a net gain of 115 holders — while 628 added to existing stakes and 775 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $295M. The largest seller was Massachusetts Financial Services, cutting an estimated $281M.

  • 1,848 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2020, up from 1,749 in Q2 2020.
  • Funds reported $156B of Thermo Fisher Scientific stock for Q3 2020, up 22% quarter-over-quarter.
  • 171 funds opened new Thermo Fisher Scientific positions in Q3 2020 and 56 closed out, a net change of +115 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2020 was Fidelity Investments, an estimated $295M added.
  • The largest Thermo Fisher Scientific seller in Q3 2020 was Massachusetts Financial Services, an estimated $281M sold.

Based on aggregated 13F filings for Q3 2020.